126 related articles for article (PubMed ID: 17510589)
1. Quality of life of Chinese patients with ovarian malignancies during chemotherapy under condition of no recurrence.
Ding Y; Zhu YL; Zhang MF
Cancer Nurs; 2007; 30(3):243-51. PubMed ID: 17510589
[TBL] [Abstract][Full Text] [Related]
2. Social support of Chinese patients with ovarian malignancies during chemotherapy: a cohort questionnaire survey.
Ding Y; Zhang MF; Zhu YL
Int J Nurs Stud; 2008 Aug; 45(8):1205-13. PubMed ID: 17905254
[TBL] [Abstract][Full Text] [Related]
3. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy.
von Gruenigen VE; Frasure HE; Jenison EL; Hopkins MP; Gil KM
Gynecol Oncol; 2006 Oct; 103(1):120-6. PubMed ID: 16556458
[TBL] [Abstract][Full Text] [Related]
5. A qualitative analysis of social concerns of women with ovarian cancer.
Ferrell BR; Smith SL; Ervin KS; Itano J; Melancon C
Psychooncology; 2003; 12(7):647-63. PubMed ID: 14502590
[TBL] [Abstract][Full Text] [Related]
6. Living with ovarian cancer.
Guidozzi F
Gynecol Oncol; 1993 Aug; 50(2):202-7. PubMed ID: 8397153
[TBL] [Abstract][Full Text] [Related]
7. The association between patient satisfaction and quality of life in Chinese lung and liver cancer patients.
Wong WS; Fielding R
Med Care; 2008 Mar; 46(3):293-302. PubMed ID: 18388844
[TBL] [Abstract][Full Text] [Related]
8. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients.
Kayl AE; Meyers CA
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):24-8. PubMed ID: 16493256
[TBL] [Abstract][Full Text] [Related]
9. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
[TBL] [Abstract][Full Text] [Related]
10. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer.
Fitch MI; Turner F
Can Nurse; 2006 Jan; 102(1):16-20. PubMed ID: 16468226
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome.
Macrì A; Maugeri I; Trimarchi G; Caminiti R; Saffioti MC; Incardona S; Sinardi A; Irato S; Altavilla G; Adamo V; Versaci A; Famulari C
In Vivo; 2009; 23(1):147-50. PubMed ID: 19368140
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal analysis of patient satisfaction and subsequent quality of life in Hong Kong Chinese breast and nasopharyngeal cancer patients.
Wong WS; Fielding R
Med Care; 2009 Aug; 47(8):875-81. PubMed ID: 19584760
[TBL] [Abstract][Full Text] [Related]
14. Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy.
de Moor JS; de Moor CA; Basen-Engquist K; Kudelka A; Bevers MW; Cohen L
Psychosom Med; 2006; 68(4):555-62. PubMed ID: 16868264
[TBL] [Abstract][Full Text] [Related]
15. Quality of life for patients with epithelial ovarian cancer.
Sun CC; Ramirez PT; Bodurka DC
Nat Clin Pract Oncol; 2007 Jan; 4(1):18-29. PubMed ID: 17183353
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study.
Karamouzis MV; Ioannidis G; Rigatos G
Eur J Cancer Care (Engl); 2007 Sep; 16(5):433-8. PubMed ID: 17760930
[TBL] [Abstract][Full Text] [Related]
17. The quality of life and self-efficacy of Turkish breast cancer patients undergoing chemotherapy.
Akin S; Can G; Durna Z; Aydiner A
Eur J Oncol Nurs; 2008 Dec; 12(5):449-56. PubMed ID: 18842460
[TBL] [Abstract][Full Text] [Related]
18. The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients.
Vernooij F; Witteveen PO; Verweij E; van der Graaf Y; Heintz AP
Gynecol Oncol; 2009 Dec; 115(3):343-8. PubMed ID: 19800674
[TBL] [Abstract][Full Text] [Related]
19. Nonbreast second malignancies after treatment of primary breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
[TBL] [Abstract][Full Text] [Related]
20. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.
Suzuki Y; Tokuda Y; Fujiwara Y; Minami H; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2008 Mar; 38(3):214-21. PubMed ID: 18296425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
